DeepIntent Wins Best Buy-Side Programmatic Platform in 2020 Digiday Technology Awards

NEW YORK, November 17, 2020 – DeepIntent, the leading healthcare marketing technology company purpose-built to influence positive health outcomes, today announced that its healthcare demand-side platform (DSP) won Best Buy-Side Programmatic Platform in the 2020 Digiday Technology Awards. The awards recognize the technology bringing transparency, efficiency, and effectiveness to the media and marketing processes for brands, agencies and publishers. DeepIntent was a finalist against leading advertising and marketing technology companies such as Xandr, Verizon Media, Cognitiv, Liftoff and Smadex.

“We’re honored to be awarded by Digiday for the success of our healthcare DSP,” said Chris Paquette, co-founder, and chief executive officer, DeepIntent. “Healthcare marketers have unique requirements around data use, inventory, and reporting underpinned by strict adherence to privacy regulations and specialized integrations for targeting and reporting. They require a platform like the DeepIntent Healthcare DSP to address their unique requirements in an effective, efficient, privacy-safe, and transparent way.”

Launched in 2019 with more than ten major pharmaceutical brands, the DeepIntent Healthcare Marketing Platform removes the complexities inherent in planning and activating data-driven campaigns. It orchestrates data deliveries and coordinates vendor list matches by centralizing and connecting all campaign activities within a single platform. Its applications— Planner and the DSP—work in harmony so marketers can quickly and easily create strategic audiences, address them immediately, and measure and optimize campaigns in-flight. By providing access to over 1.6 million verified healthcare providers and over 300 million patients, healthcare marketers can find their most clinically-relevant audiences with speed and precision.

This honor comes off the back of DeepIntent CEO and Co-Founder, Chris Paquette, winning PM360’s 2020 Trailblazer Vanguard Award for his work in creating an industry-first healthcare-specific programmatic platform.

About DeepIntent

Conceived by former Memorial Sloan Kettering data scientists, DeepIntent connects healthcare companies with patients and providers across every screen through unique data, premium media partnerships, and custom integrations. From campaign planning to audience targeting to outcomes measurement, DeepIntent is proven to increase script lift by 10% or more while improving the quality of life for patients. Powered by MarketMatch®, DeepIntent’s Healthcare Marketing Platform enables over 20 major pharmaceutical companies and dozens of media agencies to advertise to more than 200 healthcare brands, so health and treatment decisions are made based on the latest, most pertinent information. For more information, visit deepintent.com.

Press Contact

Finn Partners for DeepIntent

Zander Wharton

[email protected]

203-733-2815

More News

couple on couch watching tv
Press Release
DeepIntent Celebrates Robust Year-Over-Year Growth as Healthcare Marketers Invest in Digital Channels, Particularly CTV
More than 600 pharmaceutical brands now use DeepIntent to simplify campaign planning, activation, measurement, and optimization NEW YORK, January 11, 2023 - DeepIntent, the...
Read More
Audience Marketplace PM360 Most Innovative Products of 2022
Press Release
Audience Marketplace Named by PM360 as One of the Most Innovative Products of 2022
NEW YORK, Dec. 15, 2022 — PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries,...
Read More
What is a demand side platform
Press Release
DeepIntent Unveils the Fastest Omnichannel Campaign Measurement Tool with Near-Real Time Script Lift at Digital Pharma East
Follows Recent Launch of DeepIntent’s Innovative Patient Planner to Simplify Audience Creation and Campaign Activation NEW YORK, October 17, 2022 - DeepIntent, the leading...
Read More
Back to Top